Aurobindo Pharma Limited
Drug manufacturer · manufacturer
Unclaimed listing
1,035
Drug products
12
Therapeutic areas
About
Aurobindo Pharma Limited is listed in the FDA National Drug Code Directory with 1,035 marketed products, of which 1,031 are prescription drugs. Dosage forms include CAPSULE, POWDER, TABLET, SOLUTION, KIT. Portfolio includes DEA-scheduled controlled substances.
What Aurobindo Pharma Limited makes
1,035 productsOther · 597Cardiovascular · 134Anti-infective · 97CNS & Psychiatry · 71Immunology & Inflammation · 61Gastrointestinal · 27Nutrition & Supplements · 12Hormones & Endocrine · 12Respiratory & Allergy · 9Pain & Anesthesia · 6
tablet · 714capsule · 185powder · 32solution · 30kit · 23granule · 12suspension · 9solution/ drops · 8gel · 7cream · 6
- Abacavirabacavirtablet, film coatedoralANDA
- Abacavir and Lamivudineabacavir and lamivudinetablet, film coatedoralANDA
- Abacavirabacavir sulfatesolutionoralANDA
- ACETAZOLAMIDEacetazolamidetabletoralANDA
- ACETAZOLAMIDEacetazolamidetabletoralANDA
- ACYCLOVIRacyclovirsuspensionoralANDA
- ACYCLOVIRacyclovirtabletoralANDA
- ACYCLOVIRacyclovirtabletoralANDA
- Adapalene and benzoyl peroxideadapalene and benzoyl peroxidegeltopicalANDA
- AlbuterolalbuteroltabletoralANDA
- AlbuterolalbuteroltabletoralANDA
- ALBUTEROL SULFATEalbuterol sulfatesolutionrespiratory (inhalation)ANDA
- ALBUTEROL SULFATEalbuterol sulfatesolutionrespiratory (inhalation)ANDA
- ALBUTEROL SULFATEalbuterol sulfatesolutionrespiratory (inhalation)ANDA
- Alendronate Sodiumalendronate sodiumtabletoralANDA
- Alendronate Sodiumalendronate sodiumtabletoralANDA
- Alendronate Sodiumalendronate sodiumtabletoralANDA
- Alfuzosin Hydrochloridealfuzosin hydrochloridetablet, film coated, extended releaseoralANDA
- Alfuzosin Hydrochloridealfuzosin hydrochloridetablet, film coated, extended releaseoralANDA
- AllopurinolallopurinoltabletoralANDA
- AllopurinolallopurinoltabletoralANDA
- Alprazolamalprazolamtablet, extended releaseoralANDACIV
- Alprazolamalprazolamtablet, extended releaseoralANDACIV
- Alprazolamalprazolamtablet, extended releaseoralANDACIV
Page 1 of 44Next ›
Contact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing